The Southern states present a unique cannabis ecosystem where hemp markets have flourished years before medical cannabis programs were established. This dynamic creates both challenges and opportunities for patients, businesses, and regulators seeking to understand how these parallel markets can coexist effectively.

During a recent Qredible Live broadcast, Judson Hill, Georgia Market President of Fine Fettle and one of only six licensed medical cannabis operators in the state, offered insights into how hemp and medical cannabis markets are developing side-by-side in Georgia and across the South. This discussion highlighted the distinctive ways these complementary markets serve different consumer needs while facing their own regulatory challenges.

The Hemp Market's Head Start in the South

Hemp products have been widely available throughout the South since the 2018 Farm Bill legalized hemp nationally. This early access has shaped consumer expectations and behaviors in ways that medical cannabis programs must now consider.

"In the South, it's been interesting because these hemp products have been sold for the past six or seven years now since the Farm Bill passed," Hill explained. "So you've got a whole part of the country that's really trained more to think of the hemp products, the CBD shops and all as their place to get cannabis because that came on earlier and has been more prevalent than the medical operators."

This is especially notable in states like South Carolina, North Carolina, and Tennessee, which still lack medical cannabis programs entirely but have robust hemp markets. "They have more hemp stuff going on than you'll see anywhere else in the country," Hill observed.

Georgia's Approach to Hemp Regulation

Georgia has taken proactive steps to regulate its hemp market appropriately. Hill praised the state's balanced approach: "They've done a great job of being one of the first states to put in proper regulations for hemp that didn't kill the whole industry, but also didn't allow for a free-for-all."

In 2024, Georgia passed legislation requiring hemp businesses to register with the Department of Agriculture:

"That was last year in 2024, a bill passed that put in regulations for the hemp markets requiring retailers, manufacturers, distributors, etc., to register with the Department of Agriculture and get a license. It also outlawed products like THCA and other products that were coming in from other states and may or may not have been what the hemp program was really intending."

Hill noted that Georgia has also been supportive of hemp beverages, which he views as "a great alternative to alcohol" and a way to normalize cannabis consumption in mainstream settings.

Medical Cannabis: A Different Focus and Structure

While the hemp market serves wellness and recreational consumers, Georgia's medical cannabis program operates under stricter regulations with a clear pharmaceutical approach. As one of only six licensed operators in Georgia, Hill's company, Fine Fettle, embodies this medical focus:

"We're basically creating a farm-to-table medicine. Everything is grown in our facility, manufactured in our facility, and goes straight to the dispensaries, which is very different from the hemp market or even like the California regulated cannabis market, where I come from, of a very interchangeable supply chain."

This vertical integration provides quality control advantages that benefit medical patients requiring consistent products. "When you're providing a product to people with serious medical conditions... you can't just rely on whatever inputs were sourced because that was what was available or the best price at the time," Hill explained.

Testing and Quality Assurance Differences

Both markets require product testing, but with different standards and oversight. Hill described how Fine Fettle's medical products undergo rigorous laboratory testing as required by regulations.

For hemp products, Georgia has authorized six testing laboratories. "A couple are in Georgia and a couple are nationwide like the top labs," Hill noted. He explained that most major hemp brands source their ingredients from the same few manufacturers, creating some standardization in the supply chain.

"Most of the top brands are all sourcing from the same few manufacturers of the input ingredient. So it is a pretty trusted supply chain if you're following the regulations, in my opinion."

Complementary Markets Serving Different Needs

Rather than seeing hemp and medical cannabis as competitors, Hill envisions these markets serving complementary roles in consumers' lives:

"I guess how I would see the future is more leaning into the regulated channels to supply that medical-grade product and then allowing these low-dose hemp products with proper regulation to be sold as more of a wellness or alcohol replacement."

This dual-track approach allows for different points of entry for consumers. "Those can be a good entry point by going to a convenience store and getting a hemp beverage rather than getting a fifth of vodka or a 30-pack of beer or whatever it is," Hill suggested.

Meanwhile, dispensaries can focus on "that medical-focused quality product that's treated like medicine is" for patients with more serious conditions.

Education and Regulatory Alignment

For these parallel markets to thrive, education remains crucial. The recently announced blue ribbon study committee in Georgia will examine both medical cannabis and hemp, potentially creating more regulatory alignment between the markets.

"I think the speaker has clearly taken it upon himself and the legislature to prioritize the education of both medical cannabis and hemp," Hill noted. This educational initiative could help lawmakers create more cohesive policies that recognize the distinct roles of each market while ensuring consumer safety across both.

The Future of Dual Cannabis Markets in the South

As the South continues developing its approach to cannabis, the distinction between hemp and medical markets will likely remain important. Hill's vision suggests a future where consumers can access different cannabis products through different channels based on their needs—low-dose hemp products for wellness and social consumption, and regulated medical cannabis for specific health conditions.

This model may prove particularly fitting for conservative Southern states, allowing them to maintain strict medical oversight while still permitting broader access to hemp products with consumer protections in place.

For businesses operating in these spaces, understanding the distinctions between markets—from regulatory requirements to consumer expectations—will be essential for success in the unique cannabis ecosystem emerging across the American South.